Overview
Atinary provides an AI-driven R&D platform called SDLabs that integrates machine learning optimizers, data analytics, and visualization to accelerate experiment design and optimization in life sciences and pharma. The platform supports Self-Driving Labs with closed-loop Design-Make-Test-Analyze-Learn cycles, automating multi-objective optimization for process chemistry, small molecule synthesis, and catalyst development. It combines human judgment with AI and robotics from partners like ABB, Agilent, and Chemspeed for faster, scalable R&D.
Frequently asked questions
- What core capabilities does Atinary offer for pharma R&D?
- Atinary's SDLabs platform delivers AI-driven optimization via machine learning, data analytics, visualization, and closed-loop DMTA+L cycles for experiment design, execution, analysis, and learning in process chemistry and small molecule synthesis.
- What geographies does Atinary serve?
- Atinary operates facilities in Boston (USA) and Basel (Switzerland), with a hardware-agnostic platform deployable in customer labs worldwide.
- Is Atinary's platform compatible with lab robotics and regulatory standards?
- Yes, it integrates with robotics and instruments from ABB, Agilent, Bruker, Chemspeed, and METTLER TOLEDO, supporting no-code AI for compliant, scalable lab automation in pharma R&D.